Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Experience With a Novel Intravascular Hertz Contact Lithotripsy Balloon in Severely Calcified Coronary Lesions.

JACC. Advances·2026
Same author

The Pivotal Role of Plant Derivatives and Eicosanoid Signaling Modulation in Counteracting Cardiomiopathy.

International journal of molecular sciences·2026
Same author

Hybrid Surgical-Catheter Epicardial Ablation of Ventricular Tachycardia: A Case Series.

Journal of clinical medicine·2026
Same author

An Assessment of the Paediatric Cardiovascular Risk Profile in San Nicola da Crissa, a Village in the Calabria Region (Southern Italy): A Cross-Sectional Study.

Journal of cardiovascular development and disease·2026
Same author

Near-field substrate analysis in ventricular tachycardia: a novel approach to identify the critical isthmus.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same author

Decoding heart failure trajectories: A high-stakes challenge for remote monitoring.

International journal of cardiology·2026
Same journal

Prognostic value of preoperative peak atrial longitudinal strain for patients undergoing mitral valve surgery.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same journal

From photoshop to artificial intelligence. Scientific integrity in the modern era of cardiovascular research: a call for action.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same journal

When cancer meets acute coronary syndrome: moving beyond the 'cancer disadvantage'.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same journal

In-hospital outcomes of acute coronary syndrome in patients with cancer: a systematic review and meta-analysis.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same journal

Differentiating Takotsubo syndrome from anterior STEMI: are we getting closer?

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same journal

A new milestone for the Journal of Cardiovascular Medicine.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

ST-segment elevation during levosimendan infusion.

Francesco Barillà1, Federica Giordano, Ilaria Jacomelli

  • 1Department of Heart and Great Vessels 'Attilio Reale', La Sapienza University of Rome. francesco.barilla@uniroma1.it

Journal of Cardiovascular Medicine (Hagerstown, Md.)
|June 8, 2012
PubMed
Summary
This summary is machine-generated.

Levosimendan enhances heart contractility but may cause myocardial ischemia in acute heart failure patients. This finding is crucial for managing heart failure safely.

Related Experiment Videos

Last Updated: May 21, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Levosimendan is a calcium sensitizer used for acute decompensated severe congestive heart failure.
  • It increases myocardial contractility through positive inotropic effects.

Observation:

  • This study reports on the potential adverse effects of levosimendan infusion.
  • Specifically, the induction of myocardial ischemia was observed.

Findings:

  • Levosimendan infusion can precipitate myocardial ischemia in patients diagnosed with acute heart failure.
  • This adverse effect was noted despite its therapeutic indications.

Implications:

  • Clinicians should exercise caution when administering levosimendan to acute heart failure patients.
  • Monitoring for signs of myocardial ischemia during levosimendan therapy is recommended.